Nederlands
English Indonesia Türkçe Deutsch Español Português Pусский Français Italiano Nederlands Polski العربية ไทย Tiếng Việt 繁體中文 简体中文 日本語 한국어

#lifesciencesblog zoekresultaten

Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
21 nov. 2022

Written Description is Not Always Your Friend - by Richard Kelly featured on the Life Sciences Blog lifesciencesipblog.com/written-descri… #Oblon #LifeSciencesBlog

Oblon_IP's tweet image. Written Description is Not Always Your Friend - by Richard Kelly featured on the Life Sciences Blog lifesciencesipblog.com/written-descri… #Oblon #LifeSciencesBlog
0
0
0
0
0
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
2 aug. 2022

Read Derek Lightner's Life Sciences blog "Obviousness Must Consider Function / Intended Use of Prior Art Device" lifesciencesipblog.com/obviousness-mu… #Oblon #LifeSciencesBlog #USPTO #Obviousness #patentlaw

Oblon_IP's tweet image. Read Derek Lightner's Life Sciences blog "Obviousness Must Consider Function / Intended Use of Prior Art Device" lifesciencesipblog.com/obviousness-mu… #Oblon #LifeSciencesBlog #USPTO #Obviousness #patentlaw
3
0
0
0
0
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
12 aug. 2022

Read Elissa Sanford and Richard Kelly's latest Life Sciences Blog post lifesciencesipblog.com/biopharma-iprs… #LifeSciencesBlog #IPlaw #IPR #Oblon

Oblon_IP's tweet image. Read Elissa Sanford and Richard Kelly's latest Life Sciences Blog post lifesciencesipblog.com/biopharma-iprs… #LifeSciencesBlog #IPlaw #IPR #Oblon
0
0
0
0
0
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
7 jul. 2022

"FDA Stays Juul Ban, Announces Plan To Implement New Policies" - Read Elissa Sanford's latest blog on Oblon's Life Sciences Blog lifesciencesipblog.com/fda-stays-juul… #Oblon #LifeSciencesBlog #FDA #lifesciences #FDAUpdate #JuulBan

Oblon_IP's tweet image. "FDA Stays Juul Ban, Announces Plan To Implement New Policies" - Read Elissa Sanford's latest blog on Oblon's Life Sciences Blog lifesciencesipblog.com/fda-stays-juul… #Oblon #LifeSciencesBlog #FDA #lifesciences #FDAUpdate #JuulBan
0
0
0
0
0
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
9 aug. 2022

Read Richard Kelly's latest article on the Life Sciences Blog entitled "Teva Files Certiorari Petition in "Skinny" Label Case" lifesciencesipblog.com/teva-files-cer… #Oblon #LifeSciencesBlog #SkinnyLabels #lifesciences

Oblon_IP's tweet image. Read Richard Kelly's latest article on the Life Sciences Blog entitled "Teva Files Certiorari Petition in "Skinny" Label Case" lifesciencesipblog.com/teva-files-cer… #Oblon #LifeSciencesBlog #SkinnyLabels #lifesciences
0
0
0
0
0
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
26 okt. 2022

Read Marina Miller's new post on the Life Sciences Blog "A Class of 957 Predicted Salts Is Insufficient To Meet the ‘At Once Envisage' Standard." lifesciencesipblog.com/a-class-of-957… #Oblon #LifeSciencesBlog #Pharmaceuticals #patentelaw #USPTO #FederalCircuit

Oblon_IP's tweet image. Read Marina Miller's new post on the Life Sciences Blog "A Class of 957 Predicted Salts Is Insufficient To Meet the ‘At Once Envisage' Standard." lifesciencesipblog.com/a-class-of-957… #Oblon #LifeSciencesBlog #Pharmaceuticals #patentelaw #USPTO #FederalCircuit
0
1
2
0
0
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
24 jan. 2023

CAFC Affirms Obviousness Rejections Regarding Lack of Motivation to Combine - read this latest update on the Life Sciences IP Blog by Kasumi Kanetaka & Grace Kim. lifesciencesipblog.com/cafc-affirms-o… #LifeSciencesblog #CAFC #FederalCircuit

Oblon_IP's tweet image. CAFC Affirms Obviousness Rejections Regarding Lack of Motivation to Combine - read this latest update on the Life Sciences IP Blog by Kasumi Kanetaka & Grace Kim. lifesciencesipblog.com/cafc-affirms-o… #LifeSciencesblog #CAFC #FederalCircuit
0
0
0
0
427
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
3 mrt. 2023

Read the latest Life Sciences Blog update by Sara Pistilli, PharmD and Richard Kelly entitled "Federal Circuit Reiterates: Isolated Natural Products Alone Are Not Patent Eligible Without A Markedly Different Characteristic" #Oblon #CAFC #LifeSciencesBlog lifesciencesipblog.com/federal-circui…

Oblon_IP's tweet image. Read the latest Life Sciences Blog update by Sara Pistilli, PharmD and Richard Kelly entitled "Federal Circuit Reiterates: Isolated Natural Products Alone Are Not Patent Eligible Without A Markedly Different Characteristic" #Oblon #CAFC #LifeSciencesBlog lifesciencesipblog.com/federal-circui…
0
0
0
0
301
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
12 nov. 2022

Read Oblon's latest Life Sciences Blog post written by Derek Lightner, PhD: lifesciencesipblog.com/ptab-overturns…. #Oblon #LifeSciencesBlog #PTAB #patentlaw @uspto

Oblon_IP's tweet image. Read Oblon's latest Life Sciences Blog post written by Derek Lightner, PhD: lifesciencesipblog.com/ptab-overturns…. #Oblon #LifeSciencesBlog #PTAB #patentlaw @uspto
0
0
0
0
0
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
3 mrt. 2023

Read the latest Life Sciences Blog update by Sara Pistilli, PharmD and Richard Kelly entitled "Federal Circuit Reiterates: Isolated Natural Products Alone Are Not Patent Eligible Without A Markedly Different Characteristic" #Oblon #CAFC #LifeSciencesBlog lifesciencesipblog.com/federal-circui…

Oblon_IP's tweet image. Read the latest Life Sciences Blog update by Sara Pistilli, PharmD and Richard Kelly entitled "Federal Circuit Reiterates: Isolated Natural Products Alone Are Not Patent Eligible Without A Markedly Different Characteristic" #Oblon #CAFC #LifeSciencesBlog lifesciencesipblog.com/federal-circui…
0
0
0
0
301
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
24 jan. 2023

CAFC Affirms Obviousness Rejections Regarding Lack of Motivation to Combine - read this latest update on the Life Sciences IP Blog by Kasumi Kanetaka & Grace Kim. lifesciencesipblog.com/cafc-affirms-o… #LifeSciencesblog #CAFC #FederalCircuit

Oblon_IP's tweet image. CAFC Affirms Obviousness Rejections Regarding Lack of Motivation to Combine - read this latest update on the Life Sciences IP Blog by Kasumi Kanetaka & Grace Kim. lifesciencesipblog.com/cafc-affirms-o… #LifeSciencesblog #CAFC #FederalCircuit
0
0
0
0
427
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
21 nov. 2022

Written Description is Not Always Your Friend - by Richard Kelly featured on the Life Sciences Blog lifesciencesipblog.com/written-descri… #Oblon #LifeSciencesBlog

Oblon_IP's tweet image. Written Description is Not Always Your Friend - by Richard Kelly featured on the Life Sciences Blog lifesciencesipblog.com/written-descri… #Oblon #LifeSciencesBlog
0
0
0
0
0
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
12 nov. 2022

Read Oblon's latest Life Sciences Blog post written by Derek Lightner, PhD: lifesciencesipblog.com/ptab-overturns…. #Oblon #LifeSciencesBlog #PTAB #patentlaw @uspto

Oblon_IP's tweet image. Read Oblon's latest Life Sciences Blog post written by Derek Lightner, PhD: lifesciencesipblog.com/ptab-overturns…. #Oblon #LifeSciencesBlog #PTAB #patentlaw @uspto
0
0
0
0
0
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
26 okt. 2022

Read Marina Miller's new post on the Life Sciences Blog "A Class of 957 Predicted Salts Is Insufficient To Meet the ‘At Once Envisage' Standard." lifesciencesipblog.com/a-class-of-957… #Oblon #LifeSciencesBlog #Pharmaceuticals #patentelaw #USPTO #FederalCircuit

Oblon_IP's tweet image. Read Marina Miller's new post on the Life Sciences Blog "A Class of 957 Predicted Salts Is Insufficient To Meet the ‘At Once Envisage' Standard." lifesciencesipblog.com/a-class-of-957… #Oblon #LifeSciencesBlog #Pharmaceuticals #patentelaw #USPTO #FederalCircuit
0
1
2
0
0
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
12 aug. 2022

Read Elissa Sanford and Richard Kelly's latest Life Sciences Blog post lifesciencesipblog.com/biopharma-iprs… #LifeSciencesBlog #IPlaw #IPR #Oblon

Oblon_IP's tweet image. Read Elissa Sanford and Richard Kelly's latest Life Sciences Blog post lifesciencesipblog.com/biopharma-iprs… #LifeSciencesBlog #IPlaw #IPR #Oblon
0
0
0
0
0
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
9 aug. 2022

Read Richard Kelly's latest article on the Life Sciences Blog entitled "Teva Files Certiorari Petition in "Skinny" Label Case" lifesciencesipblog.com/teva-files-cer… #Oblon #LifeSciencesBlog #SkinnyLabels #lifesciences

Oblon_IP's tweet image. Read Richard Kelly's latest article on the Life Sciences Blog entitled "Teva Files Certiorari Petition in "Skinny" Label Case" lifesciencesipblog.com/teva-files-cer… #Oblon #LifeSciencesBlog #SkinnyLabels #lifesciences
0
0
0
0
0
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
2 aug. 2022

Read Derek Lightner's Life Sciences blog "Obviousness Must Consider Function / Intended Use of Prior Art Device" lifesciencesipblog.com/obviousness-mu… #Oblon #LifeSciencesBlog #USPTO #Obviousness #patentlaw

Oblon_IP's tweet image. Read Derek Lightner's Life Sciences blog "Obviousness Must Consider Function / Intended Use of Prior Art Device" lifesciencesipblog.com/obviousness-mu… #Oblon #LifeSciencesBlog #USPTO #Obviousness #patentlaw
3
0
0
0
0
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
7 jul. 2022

"FDA Stays Juul Ban, Announces Plan To Implement New Policies" - Read Elissa Sanford's latest blog on Oblon's Life Sciences Blog lifesciencesipblog.com/fda-stays-juul… #Oblon #LifeSciencesBlog #FDA #lifesciences #FDAUpdate #JuulBan

Oblon_IP's tweet image. "FDA Stays Juul Ban, Announces Plan To Implement New Policies" - Read Elissa Sanford's latest blog on Oblon's Life Sciences Blog lifesciencesipblog.com/fda-stays-juul… #Oblon #LifeSciencesBlog #FDA #lifesciences #FDAUpdate #JuulBan
0
0
0
0
0
Geen resultaten voor "#lifesciencesblog"
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
21 nov. 2022

Written Description is Not Always Your Friend - by Richard Kelly featured on the Life Sciences Blog lifesciencesipblog.com/written-descri… #Oblon #LifeSciencesBlog

Oblon_IP's tweet image. Written Description is Not Always Your Friend - by Richard Kelly featured on the Life Sciences Blog lifesciencesipblog.com/written-descri… #Oblon #LifeSciencesBlog
0
0
0
0
0
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
2 aug. 2022

Read Derek Lightner's Life Sciences blog "Obviousness Must Consider Function / Intended Use of Prior Art Device" lifesciencesipblog.com/obviousness-mu… #Oblon #LifeSciencesBlog #USPTO #Obviousness #patentlaw

Oblon_IP's tweet image. Read Derek Lightner's Life Sciences blog "Obviousness Must Consider Function / Intended Use of Prior Art Device" lifesciencesipblog.com/obviousness-mu… #Oblon #LifeSciencesBlog #USPTO #Obviousness #patentlaw
3
0
0
0
0
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
12 aug. 2022

Read Elissa Sanford and Richard Kelly's latest Life Sciences Blog post lifesciencesipblog.com/biopharma-iprs… #LifeSciencesBlog #IPlaw #IPR #Oblon

Oblon_IP's tweet image. Read Elissa Sanford and Richard Kelly's latest Life Sciences Blog post lifesciencesipblog.com/biopharma-iprs… #LifeSciencesBlog #IPlaw #IPR #Oblon
0
0
0
0
0
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
12 nov. 2022

Read Oblon's latest Life Sciences Blog post written by Derek Lightner, PhD: lifesciencesipblog.com/ptab-overturns…. #Oblon #LifeSciencesBlog #PTAB #patentlaw @uspto

Oblon_IP's tweet image. Read Oblon's latest Life Sciences Blog post written by Derek Lightner, PhD: lifesciencesipblog.com/ptab-overturns…. #Oblon #LifeSciencesBlog #PTAB #patentlaw @uspto
0
0
0
0
0
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
9 aug. 2022

Read Richard Kelly's latest article on the Life Sciences Blog entitled "Teva Files Certiorari Petition in "Skinny" Label Case" lifesciencesipblog.com/teva-files-cer… #Oblon #LifeSciencesBlog #SkinnyLabels #lifesciences

Oblon_IP's tweet image. Read Richard Kelly's latest article on the Life Sciences Blog entitled "Teva Files Certiorari Petition in "Skinny" Label Case" lifesciencesipblog.com/teva-files-cer… #Oblon #LifeSciencesBlog #SkinnyLabels #lifesciences
0
0
0
0
0
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
7 jul. 2022

"FDA Stays Juul Ban, Announces Plan To Implement New Policies" - Read Elissa Sanford's latest blog on Oblon's Life Sciences Blog lifesciencesipblog.com/fda-stays-juul… #Oblon #LifeSciencesBlog #FDA #lifesciences #FDAUpdate #JuulBan

Oblon_IP's tweet image. "FDA Stays Juul Ban, Announces Plan To Implement New Policies" - Read Elissa Sanford's latest blog on Oblon's Life Sciences Blog lifesciencesipblog.com/fda-stays-juul… #Oblon #LifeSciencesBlog #FDA #lifesciences #FDAUpdate #JuulBan
0
0
0
0
0
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
26 okt. 2022

Read Marina Miller's new post on the Life Sciences Blog "A Class of 957 Predicted Salts Is Insufficient To Meet the ‘At Once Envisage' Standard." lifesciencesipblog.com/a-class-of-957… #Oblon #LifeSciencesBlog #Pharmaceuticals #patentelaw #USPTO #FederalCircuit

Oblon_IP's tweet image. Read Marina Miller's new post on the Life Sciences Blog "A Class of 957 Predicted Salts Is Insufficient To Meet the ‘At Once Envisage' Standard." lifesciencesipblog.com/a-class-of-957… #Oblon #LifeSciencesBlog #Pharmaceuticals #patentelaw #USPTO #FederalCircuit
0
1
2
0
0
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
24 jan. 2023

CAFC Affirms Obviousness Rejections Regarding Lack of Motivation to Combine - read this latest update on the Life Sciences IP Blog by Kasumi Kanetaka & Grace Kim. lifesciencesipblog.com/cafc-affirms-o… #LifeSciencesblog #CAFC #FederalCircuit

Oblon_IP's tweet image. CAFC Affirms Obviousness Rejections Regarding Lack of Motivation to Combine - read this latest update on the Life Sciences IP Blog by Kasumi Kanetaka & Grace Kim. lifesciencesipblog.com/cafc-affirms-o… #LifeSciencesblog #CAFC #FederalCircuit
0
0
0
0
427
Oblon_IP's profile picture. Partnering with some of the world's most innovative companies to establish, leverage and protect their IP assets. *Tweets by marketing team*
Oblon
 @Oblon_IP
3 mrt. 2023

Read the latest Life Sciences Blog update by Sara Pistilli, PharmD and Richard Kelly entitled "Federal Circuit Reiterates: Isolated Natural Products Alone Are Not Patent Eligible Without A Markedly Different Characteristic" #Oblon #CAFC #LifeSciencesBlog lifesciencesipblog.com/federal-circui…

Oblon_IP's tweet image. Read the latest Life Sciences Blog update by Sara Pistilli, PharmD and Richard Kelly entitled "Federal Circuit Reiterates: Isolated Natural Products Alone Are Not Patent Eligible Without A Markedly Different Characteristic" #Oblon #CAFC #LifeSciencesBlog lifesciencesipblog.com/federal-circui…
0
0
0
0
301

Something went wrong.


Something went wrong.


United States Trends